Navamedic ASA (NAVA) - Total Liabilities
Based on the latest financial reports, Navamedic ASA (NAVA) has total liabilities worth Nkr350.53 Million NOK (≈ $36.89 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Navamedic ASA's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Navamedic ASA - Total Liabilities Trend (2003–2025)
This chart illustrates how Navamedic ASA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Navamedic ASA.
Navamedic ASA Competitors by Total Liabilities
The table below lists competitors of Navamedic ASA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tamul Multimedia Co. Ltd
KQ:093640
|
Korea | ₩32.86 Billion |
|
Dr Peng Telecom and Media Group Co Ltd
SHG:600804
|
China | CN¥7.58 Billion |
|
ContextVision AB
OL:CONTX
|
Norway | Nkr35.12 Million |
|
Risma Systems AS
CO:RISMA
|
Denmark | Dkr34.76 Million |
|
American West Metals Ltd
AU:AW1
|
Australia | AU$13.81 Million |
|
DONGJIANG ENVIRONMENTAL H
F:DGN
|
Germany | €7.09 Billion |
|
Network-1 Technologies Inc
NYSE MKT:NTIP
|
USA | $512.00K |
|
Chow Steel Industries Public Company Limited
BK:CHOW
|
Thailand | ฿674.73 Million |
Liability Composition Analysis (2003–2025)
This chart breaks down Navamedic ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Navamedic ASA (NAVA) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Navamedic ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Navamedic ASA (2003–2025)
The table below shows the annual total liabilities of Navamedic ASA from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Nkr407.67 Million ≈ $42.90 Million |
+62.55% |
| 2024-12-31 | Nkr250.81 Million ≈ $26.39 Million |
-16.93% |
| 2023-12-31 | Nkr301.91 Million ≈ $31.77 Million |
+74.46% |
| 2022-12-31 | Nkr173.05 Million ≈ $18.21 Million |
-3.29% |
| 2021-12-31 | Nkr178.94 Million ≈ $18.83 Million |
+37.07% |
| 2020-12-31 | Nkr130.55 Million ≈ $13.74 Million |
+21.08% |
| 2019-12-31 | Nkr107.83 Million ≈ $11.35 Million |
-6.57% |
| 2018-12-31 | Nkr115.41 Million ≈ $12.14 Million |
-23.35% |
| 2017-12-31 | Nkr150.57 Million ≈ $15.84 Million |
-17.24% |
| 2016-12-31 | Nkr181.94 Million ≈ $19.15 Million |
+15.68% |
| 2015-12-31 | Nkr157.27 Million ≈ $16.55 Million |
+54.23% |
| 2014-12-31 | Nkr101.97 Million ≈ $10.73 Million |
+41.19% |
| 2013-12-31 | Nkr72.22 Million ≈ $7.60 Million |
+94.80% |
| 2012-12-31 | Nkr37.07 Million ≈ $3.90 Million |
-19.11% |
| 2011-12-31 | Nkr45.83 Million ≈ $4.82 Million |
+98.24% |
| 2010-12-31 | Nkr23.12 Million ≈ $2.43 Million |
-6.65% |
| 2009-12-31 | Nkr24.77 Million ≈ $2.61 Million |
-49.86% |
| 2008-12-31 | Nkr49.40 Million ≈ $5.20 Million |
-12.51% |
| 2007-12-31 | Nkr56.46 Million ≈ $5.94 Million |
-768.93% |
| 2006-12-31 | Nkr-8.44 Million ≈ $-888.25K |
-275.64% |
| 2005-12-31 | Nkr4.81 Million ≈ $505.74K |
-347.21% |
| 2004-12-31 | Nkr-1.94 Million ≈ $-204.58K |
-69.81% |
| 2003-12-31 | Nkr-6.44 Million ≈ $-677.59K |
-- |
About Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition… Read more